Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Victoria

$25,000.00

Chemical synthesis of novel immunogens for post-translational-modification specific antibodies

EF 2013-14

Résumé
Stressmarq Biosciences is a company that supplies biochemical reagents to researchers in the life sciences.They create and sell antibodies, which are biomolecules that have highly specific binding abilities for specificmolecular targets. Antibodies are important bioreagents that are used in a wide variety of analyticalapplications - their ability to bind a specific molecular target is central to the detection, measurement, andquantification of the presence of that target in a variety of research fields. Each antibody generation projectmust start with an immunogen, which is a molecule that represents the target structure, and that can be usedtogether with an animal's immune system to generate an antibody of the required specificity.Post-translational modifications are a collection of biomolecular targets (modified proteins) that are increasingin importance as our growing understanding of them shows them to be important in a wide variety offundamental cellular processes. But antibodies against post-translationally modified proteins have twoproblems: they are notoriously low-quality, and there are many post-translationally modified proteins for whichantibodies simply don't exist. This project will address both of these problems by taking new approaches to thedevelopment of the chemical agents that are used to produce antibodies. We have identified four groups oftargets that would be of high value to Stressmarq. For each group, we will ask the questions, ""Is there a newimmunogen design that will allow us to push this field further forward?"" ""Can we make these newimmunogens? ""Are our new designs able to elicit the required immune response and generate the requiredantibodies?"" Close collaboration between our chemistry lab and Stressmarq's antibody team will ensure that theproject generates new products and opens new markets to the company.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
452234-2013
Name nom
Hof, Fraser
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Chemical synthesis of novel immunogens for post-translational-modification specific antibodies
Keyword
NSERC
Application summary
Stressmarq Biosciences is a company that supplies biochemical reagents to researchers in the life sciences.They create and sell antibodies, which are biomolecules that have highly specific binding abilities for specificmolecular targets. Antibodies are important bioreagents that are used in a wide variety of analyticalapplications - their ability to bind a specific molecular target is central to the detection, measurement, andquantification of the presence of that target in a variety of research fields. Each antibody generation projectmust start with an immunogen, which is a molecule that represents the target structure, and that can be usedtogether with an animal's immune system to generate an antibody of the required specificity.Post-translational modifications are a collection of biomolecular targets (modified proteins) that are increasingin importance as our growing understanding of them shows them to be important in a wide variety offundamental cellular processes. But antibodies against post-translationally modified proteins have twoproblems: they are notoriously low-quality, and there are many post-translationally modified proteins for whichantibodies simply don't exist. This project will address both of these problems by taking new approaches to thedevelopment of the chemical agents that are used to produce antibodies. We have identified four groups oftargets that would be of high value to Stressmarq. For each group, we will ask the questions, ""Is there a newimmunogen design that will allow us to push this field further forward?"" ""Can we make these newimmunogens? ""Are our new designs able to elicit the required immune response and generate the requiredantibodies?"" Close collaboration between our chemistry lab and Stressmarq's antibody team will ensure that theproject generates new products and opens new markets to the company.